Table 1.
Groups | Diagnostic Process | |||||||
---|---|---|---|---|---|---|---|---|
1, Serological Screening | 2, Serological Validation | 3, Parasitological Confirmation | 4, Staging | No. of Subjects |
||||
CATTwb / RDT | CATTpa | mAECT BC / LN aspirate observation | Parasites in CSF | No. WBCs in CSF | Screened | Enrolled | Followed Up | |
Seronegative | − | ND | ND | ND | 5377 | 40 | 0 | |
+ | <1/4 | |||||||
Seropositive | + | ≥1/4 | − | ND | 12 | 8 | 5 | |
Confirmed | + | ≥1/4 | + | |||||
Stage 1 | No | 0–5 | 8 | 4 | 4 | |||
Stage 2 | Yes | >5 | 18 | 14 | 13 | |||
ND | ND | 2 | 0 | 0 | ||||
All | 28 | 18 | 17 | |||||
Total | 5417 | 66 | 22 |
Abbreviations: CATTp, card agglutination test for trypanosomiasis on plasma; CATTwb, card agglutination test for trypanosomiasis on whole blood; CSF, cerebrospinal fluid; mAECT BC/LN aspirate, mini anion-exchange column technique on buffy coat/lymph node aspirate; ND, not determined; WBC, white blood cell.
aHighest plasma dilution with a positive result.